# Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer

Source: https://onco.cc/trials/nct06709144/  
OnCo record `nct06709144` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in colorectal cancer, run by Haixing Ju, MD, active but no longer recruiting.

## Summary

Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer is a phase 3, randomised interventional study registered as NCT06709144 by Haixing Ju, MD, with a registry enrolment figure of 896 participants, started 2024-07-01 and due to reach its primary completion in 2027-06-30. Interventions recorded: SMA lymph node dissection; SMV lymph node dissection. Conditions listed: Colon Cancer. Primary outcome: 3 year DFS. Colorectal eligibility wording from the registry: "* right side colon cancer(The primary lesion is located in the ileocecal region, ascending colon, hepatic flexure of colon, or proximal transverse colon)". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-24
- Also known as: BLARCC
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT06709144
- Phase: 3
- Setting: Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer(BLARCC): a Prospective, Multicenter Randomized Control Clinical Trial
- Sponsor: Haixing Ju, MD
- Enrolled: 896

## Sources

- ClinicalTrials.gov NCT06709144: https://clinicaltrials.gov/study/NCT06709144

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06709144.json